lobbying_activities: 1957989

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1957989	4a5cd2f7-c3ca-43bf-9ba8-c8a3aae18e1f	Q1	GREENBERG TRAURIG, LLP	16896	BAYER CORPORATION	2017	first_quarter	HCR	Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to dietary supplements. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. Monitor legislative and administrative action related to Affordable Care Act repeal. Outreach related to pharmaceutical industry marketing practices. H.R. 277 American Health Care Reform Act of 2017. H.R. 1628 American Health Care Act of 2017. S. 222 Obamacare Replacement Act. H.Res.228, Providing for consideration of the bill (H.R. 1628) to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017.	Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE	120000		0	0	2017-04-18T21:12:49.673000-04:00